Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and New York Stock Exchange as ACB. As of late September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 25 countries.
From Zacks:
Aurora Cannabis Inc. (ACB) closed at $2.07 in the latest trading session, marking a +1.47% move from the prior day. The stock outpaced the S&P 500’s daily gain of 0.11%. Elsewhere, the Dow lost 0.09%, while the tech-heavy Nasdaq added 0.2%.
Heading into today, shares of the company had gained 2.51% over the past month, outpacing the Medical sector’s gain of 0.94% and lagging the S&P 500’s gain of 3.25% in that time.
Wall Street will be looking for positivity from ACB as it approaches its next earnings report date. The company is expected to report EPS of -$0.04, unchanged from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $62.22 million, up 51.76% from the year-ago period.
